Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1Neoplasm Metastasis 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Paclitaxel 5Carboplatin 5Docetaxel 4Cisplatin 4Bevacizumab 4Taxes 3Drug Therapy 3Gemcitabine 2Fluorodeoxyglucose F18 2Cetuximab 2saracatinib 1endostar protein 1cediranib 1aflutinib 1Zoledronic Acid 1X-Rays 1Vinorelbine 1Thoracic Surgery, Video-Assisted 1Spectrum Analysis 1Silver Nitrate 1Saline Solution 1Radiotherapy, Conformal 1Radiation 1Pleurodesis 1Pemetrexed 1Nivolumab 1Naproxen 1N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea 1Morphine 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pleural Effusion, Malignant × Spectrum Analysis × Clear all
NCT00601848 2020-11-24

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Abramson Cancer Center at Penn Medicine

Phase 2 Terminated
9 enrolled 5 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡